![]() |
Cancer preventive and therapeutic compounds : gift from mother nature / edited by Sahdco Prasad & Amit Kumar Tyagi. -- Sharjah : Bentham Science Publishers, 2017. – (64.863/C215) |
Contents
FOREWORD
PREFACE
LIST OF CONTRIBUTORS
CHAPTER 1
DIETARY AGENTS: EFFECTIVE AND SAFE NATURAL ASSETS AGAINST CANCER 3
INTRODUCTION 3
FRUITS AND VEGETABLES 5
LEGUMES 8
GRAINS AND CEREALS 9
NUTS 11
SPICES 12
CONCLUSION 13
CONFLICT OF INTEREST 14
ACKNOWLEDGEMENTS 14
REFERENCES- 14
CHAPTER 2
MEDICINAL IMPORTANCE OF ALLICIN - A BIOACTIVE COMPONENT FROM ALLIUM
SATIVUM L (GARLIC) 20
INTRODUCTION 20
CONCLUDING REMARKS 26
CONFLICT OF INTEREST 26
ACKNOWLEDGEMENTS 26
REFERENCES 27
CHAPTER 3
BOSWELLIC ACIDS AS POTENTIAL CANCER THERAPEUTICS 32
INTRODUCTION 32
CONCLUSION
54
CONFLICT OF INTEREST 54
ACKNOWLEDGEMENTS 54
REFERENCES
54
CHAPTER 4
NATURAL COMPOUNDS: CANCER PREVENTIVE AGENTS 64
INTRODUCTION 64
CANCER PREVENTION THROUGH NATURAL SOURCES 65
MOLECULAR TARGETS FOR NATURAL CHEMOPREVENTIVE
AGENTS 76
CONCLUDING REMARKS 80
CONFLICT OF INTEREST 82
ACKNOWLEDGEMENTS 82
REFERENCES
82
CHAPTER 5
AFRICAN MEDICINAL PLANTS: AN UNTAPPED RESERVOIR OF POTENTIAL ANTICANCER
AGENTS 87
INTRODUCTION 87
SOME ISOLATED COMPOUNDS FROM AFRICAN MEDICINAL PLANTS WITH MEASURED
ANTICANCER ACTIVITY 89
CONCLUSION
CONFLICT OF INTEREST 99
ACKNOWLEDGEMENTS 99
REFERENCES 99
CHAPTER 6
PHYTOCHEMICALS IN THERAPY OF RADIATION INDUCED DAMAGE AND CANCER
INTRODUCTION 105
CONCLUSION
116
CONFLICT OF INTEREST 116
ACKNOWLEDGEMENT 116
REFERENCES
117
CHAPTER 7
MARINE NATURAL PRODUCTS FOR CANCER PREVENTION AND THERAPY: A MECHANISTIC
OVERVIEW 125
INTRODUCTION
125
CONFLICT OF INTEREST 140
ACKNOWLEDGEMENTS 140
REFERENCES
140
CHAPTER 8
NATURAL PRODUCTS AS A UNIQUE SOURCE OF ANTI-CANCER AGENTS 147
INTRODUCTION
147
TREATMENT MODALITIES OF CANCER 148
HISTORY OF NATURAL COMPOUNDS AS CANCER
THERAPEUTICS 150
ROLE OF MARINE NATURAL COMPOUNDS AND THEIR
DERIVATIVES IN CANCER PREVENTION
CONCLUSION
167
CONFLICT OF INTEREST 168
ACKNOWLEDGEMENTS 168
REFERENCES
168
CHAPTER 9
TRANSLATION OF NATURAL PRODUCTS INTO CLINICALLY EFFECTIVE DRUGS: HOW FAR
WE HAVE GONE 182
INTRODUCTION 183
PROSTATE CANCER 183
COLORECTAL CANCER 185
LUNG CANCER 185
HEPATOCELLULAR CARCINOMA 186
PANCREATIC CANCER 186
NATURAL PRODUCT INDUCED MODULATION OF EPIGENETIC MACHINERY 187
CONCLUSION 189
CONFLICT OF INTEREST 190
ACKNOWLEDGEMENTS 190
REFERENCES 190
SUBJECT INDEX 194